Luxembourg vs Tuvalu: The number of people with susceptibility test result for rifampicin
Luxembourg
21
in 2021
Tuvalu
19
in 2021
Luxembourg rank
132nd
Tuvalu rank
133rd
The number of people with susceptibility test result for rifampicin over time
- Luxembourg
- Tuvalu
How they compare
Luxembourg currently reports 21 against 19 in Tuvalu, a difference of 2.
That makes Luxembourg's figure about 1.1 times Tuvalu's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Tuvalu ahead.
Luxembourg ranks 132nd and Tuvalu ranks 133rd of 155 countries.
Across the 2 decades both report, Luxembourg averaged higher in 1 and Tuvalu in 1.
Head to head by decade
| Decade | Luxembourg | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.33 | 14 | 8.67 | Tuvalu |
| 2020s | 19.5 | 17 | 2.5 | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Luxembourg or Tuvalu?
- Luxembourg, at 21 against 19 in Tuvalu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Luxembourg and Tuvalu?
- 2, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do Luxembourg and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- Luxembourg ranks 132nd and Tuvalu ranks 133rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.